Kaczorek, M., et al., Molecular Cloning and Synthesis of Biologically Active Human Tissue Inhibitor of Matalloproteinases in Yeast, Bio/Technology 5:595-598 (1987). |
Uria, J.A., et al., Structure and Expression in Breast Tumors of Human TIMP-3, a New Member of the Metalloproteinase Inhibitor Family, Cancer Research 54:2091-2094 (1994). |
Shimizu, N., et al., Gene Mapping and Fine-Structure Analysis of the Human Genome Using Flow-Sorted Chromosomes, Adv. Tech. Chromosome Res., K. W. Adolph (editor), Dekker, New York, NY, 135-153 (1991). |
Rasmussen, H., et al., Matrix Metalloproteinase Inhibition as a Novel Anticancer Strategy: A Review with Special Focus on Batimastat and Marimastat, Pharmacol. Ther. 75:69-75 (1997). |
Wang, M., et al., Inhibition of tumor growth and metastatis of human breast cancer cells transfected with tissue inhibitor of metalloproteinase 4, Oncogene 14:2767-2774 (1997). |
Dollery, C., et al., TIMP-4 Is Regulated by Vascular Injury in Rats, Ann. N.Y. Acad. Sci. 878:740-741 (1999). |
Thomas, P., et al., Differential expression of matrix metalloproteinases and their inhibitors in non-small cell lung cancer, J. Pathol. 190:150-156 (2000). |
Liu, Y., et al., Preparation and Characterization of Recombinant Tissue Inhibitor of Metalloproteinase 4 (TIMP-4), J. Biol. Chem., 272:20479-20483 (1997). |
Dollery, C., et al., TIMP-4 Is Regulated by Vascular Injury in Rats, Circ. Res. 84(5):498-504 (1999). |
Stracke, J., et al., Biochemical Characterization of the Catalytic Domain of Human Matrix Metalloproteinase 19, J. Biol. Chem., 275:14809-14816 (2000). |
Bigg, H., et al., Specific, High Affinity Binding of Tissue Inhibitor of Metalloproteinases-4 (TIMP-4) to the COOH-terminal Hemopexin-like Domain of Human Gelatinase A, J. Biol. Chem., 272:15496-15500 (1997). |
Toth, M., et al., TIMP-2 Acts Synergistically with Synthetic MMP Inhibitors but not with TIMP-4 to Enhance the MT1-MMP-dependent Activation of Pro-MMP-2, JBC Papers in Press, Manuscript M006871200 (Sep. 20, 2000). |
Stetler-Stevenson, W., Matrix metalloproteinases in angiogenisis: a moving target for therapeutic intervention, J. Clinical Investigation 103:1237-1241 (1999). |
Nagase, H., Matrix Metalloproteinases J. Biol. Chem., 274:21491-21494 (1999). |
Yu, A., et al., Matrix Metalloproteinases Novel Targets for Directed Cancer Therapy, Drugs & Aging 11(3):229-244 (1997). |
Hiraoka, N., et al., Matrix Metalloproteinases Regulate Neovascularization by Acting as Pericellular Fibrinolysins, Cell 95:365-377 (1998). |
Rosenthal, E., et al., Role of membrane type 1-matrix metalloproteinase and gelatinase A in head and neck squamous cell carcinoma invation in vitro, Otolaryngology-Head and Neck Surgery 121:337-343 (1999). |
Tsunezuka, Y., et al., Expression of Membrane-type Matrix Metalloproteinase 1 (MT1-MMP) in Tumor Cells Enhances Pulmonary Metastasis in an Experimental Metastatis Assay, Cancer Research 56:5678-5683 (1996). |
Kadono, Y., et al., Transformation of Epithelial Madin-Darby Canine Kidney Cells with p60v-src Induces Expression of Membrane-Type 1 Matrix Metalloproteinase and Invasiveness, Cancer Research 58:2240-2244 (1998). |
Hotary, K., et al., Regulation of Cell Invasion and Morphogenesis in a Three-dimensional Type I Collagen Matrix by Membrane-type Matrix Metalloproteinases 1, 2, and 3, J. Cell Biology 149:1309-1323 (2000). |